DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SANDIMMUNE

« Back to Dashboard

All Clinical Trials for Sandimmune

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000936	A Study To Test An Anti-Rejection Therapy After Kidney Transplantation	Terminated	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3	1999-11-01	Kidney transplantation is often successful. However, despite aggressive anti-rejection drug therapy, some patients will reject their new kidney. This study is designed to test two anti-rejection approaches. Two medications in this study are currently used in children, but there is no information regarding which drug is safer or more effective. Survival rates in renal transplantation are unacceptably low. Therefore, there is a need for an improved post-transplant treatment, such as the induction therapy used in this study.
NCT00428064	Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	1998-05-01	To assess equivalence in the rates of functional graft survival at 12 months after transplantation in patients receiving continuous therapy with cyclosporine (CsA, Sandimmune, Neoral) and sirolimus versus induction with CsA and sirolimus followed by CsA elimination and concentration-controlled sirolimus.
NCT00520468	Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS	Completed	M.D. Anderson Cancer Center	Phase 2	2004-06-01	Objectives: Primary: To evaluate the response rate of total cytokine-immunotherapy for low-risk myelodysplastic syndromes (MDS). Secondary: To evaluate response duration, survival and side effects of the treatment.

Clinical Trial Conditions for Sandimmune

Condition Name

Condition Name for Sandimmune
Intervention	Trials
Myelodysplastic Syndrome	5
Acute Lymphoblastic Leukemia	3
Recurrent Hodgkin Lymphoma	3

Condition MeSH

Condition MeSH for Sandimmune
Intervention	Trials
Myelodysplastic Syndromes	8
Syndrome	7
Preleukemia	7

Clinical Trial Locations for Sandimmune

Trials by Country

Trials by Country for Sandimmune
Location	Trials
United States	13
Czech Republic	1
Austria	1
China	1
South Africa	1

Trials by US State

Trials by US State for Sandimmune
Location	Trials
Washington	5
New York	3
Texas	2
California	1
Massachusetts	1

Clinical Trial Progress for Sandimmune

Clinical Trial Phase

Clinical Trial Phase for Sandimmune
Clinical Trial Phase	Trials
Phase 3	3
Phase 2/Phase 3	1
Phase 2	10

Clinical Trial Status

Clinical Trial Status for Sandimmune
Clinical Trial Phase	Trials
Recruiting	7
Completed	7
Not yet recruiting	6

Clinical Trial Sponsors for Sandimmune

Sponsor Name

Sponsor Name for Sandimmune
Sponsor	Trials
National Cancer Institute (NCI)	7
Fred Hutchinson Cancer Research Center	5
M.D. Anderson Cancer Center	2

Sponsor Type

Sponsor Type for Sandimmune
Sponsor	Trials
Other	23
NIH	8
Industry	4